JP2009137824A - Method for producing tablet-form metal iodide - Google Patents
Method for producing tablet-form metal iodide Download PDFInfo
- Publication number
- JP2009137824A JP2009137824A JP2008122565A JP2008122565A JP2009137824A JP 2009137824 A JP2009137824 A JP 2009137824A JP 2008122565 A JP2008122565 A JP 2008122565A JP 2008122565 A JP2008122565 A JP 2008122565A JP 2009137824 A JP2009137824 A JP 2009137824A
- Authority
- JP
- Japan
- Prior art keywords
- metal iodide
- tablet
- powder
- iodide
- caking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910001511 metal iodide Inorganic materials 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 34
- 238000000748 compression moulding Methods 0.000 claims abstract description 9
- 238000007906 compression Methods 0.000 claims description 14
- 230000006835 compression Effects 0.000 claims description 14
- 229910001516 alkali metal iodide Inorganic materials 0.000 claims description 4
- 229910001619 alkaline earth metal iodide Inorganic materials 0.000 claims description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 36
- 238000000034 method Methods 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 11
- 238000004090 dissolution Methods 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 150000002484 inorganic compounds Chemical class 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- 239000012530 fluid Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910001507 metal halide Inorganic materials 0.000 description 2
- 150000005309 metal halides Chemical class 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- WFUBYPSJBBQSOU-UHFFFAOYSA-M rubidium iodide Chemical compound [Rb+].[I-] WFUBYPSJBBQSOU-UHFFFAOYSA-M 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 239000004484 Briquette Substances 0.000 description 1
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- CECABOMBVQNBEC-UHFFFAOYSA-K aluminium iodide Chemical compound I[Al](I)I CECABOMBVQNBEC-UHFFFAOYSA-K 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- XQPRBTXUXXVTKB-UHFFFAOYSA-M caesium iodide Chemical compound [I-].[Cs+] XQPRBTXUXXVTKB-UHFFFAOYSA-M 0.000 description 1
- 229910001640 calcium iodide Inorganic materials 0.000 description 1
- 229940046413 calcium iodide Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- KRIJWFBRWPCESA-UHFFFAOYSA-L strontium iodide Chemical compound [Sr+2].[I-].[I-] KRIJWFBRWPCESA-UHFFFAOYSA-L 0.000 description 1
- 229910001643 strontium iodide Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
- C01D3/00—Halides of sodium, potassium or alkali metals in general
- C01D3/12—Iodides
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Glanulating (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、錠剤型の金属ヨウ化物の製造方法に関する。 The present invention relates to a method for producing a tablet-type metal iodide.
ヨウ化カリウムに代表される金属ヨウ化物は、偏光膜の材料やナイロン安定剤、医薬原料等として広く用いられている。この金属ヨウ化物は通常粉末状で販売されているが、長期保管する際に次のようなことが問題となっていた。 Metal iodides typified by potassium iodide are widely used as polarizing film materials, nylon stabilizers, pharmaceutical raw materials and the like. This metal iodide is usually sold in the form of a powder, but the following has been a problem during long-term storage.
金属ヨウ化物は一般的に吸湿性が高い。よって、例えば比較的透湿性の高い低密度ポリエチレンを包装材として用いて金属ヨウ化物の粉末を保管しようとすると、金属ヨウ化物が吸湿するとともに、粉末の自重により圧密がかかり固結する。このため、保管前には粉末であった金属ヨウ化物が、数ヵ月後には大きな塊と化してしまうことがあった。また、包装材を比較的透湿性の低いものに替えた場合にはある程度固結が防止されるものの、全く固結しないということは無かった。金属ヨウ化物が固結してしまうと、これを使用する前に固結した部分を木槌等により物理的に砕く必要があり、作業性の低下が大きな問題となっていた。 Metal iodide is generally highly hygroscopic. Therefore, for example, when metal iodide powder is stored using low-density polyethylene having relatively high moisture permeability as a packaging material, the metal iodide absorbs moisture and is compacted and consolidated by its own weight. For this reason, the metal iodide, which was powder before storage, sometimes turned into a large lump after several months. Further, when the packaging material was changed to one having a relatively low moisture permeability, the caking was prevented to some extent, but it did not occur at all. When the metal iodide is solidified, it is necessary to physically crush the solidified part with a mallet before using it, which causes a significant problem in workability.
これに対して、金属ヨウ化物に代表される金属ハロゲン化物の固結防止方法等として、例えば特許文献１〜４記載の方法が提案されている。 On the other hand, for example, methods described in Patent Documents 1 to 4 have been proposed as methods for preventing caking of metal halides typified by metal iodide.
特許文献１には、金属ハロゲン化物の一種である食塩（塩化ナトリウム）の固結防止方法として、食塩にリン酸水素二ナトリウムの飽和溶液を噴霧した後に、炭酸マグネシウムの粉末を添加する方法が開示されている。
特許文献２には、作業性の高い金属ヨウ化物の顆粒を提供するために、流動層噴霧造粒乾燥機に金属ヨウ化物の水溶液を連続的に供給して、金属ヨウ化物を乾燥造粒する方法が開示されている。
特許文献３には、金属ヨウ化物の固結・凝集による塊状化を防止するために、ブリケッティング・ロール式の圧縮造粒方法を用いて、金属ヨウ化物を粒子径３ｍｍ以上の造粒体を全体の３０％以上有する金属ヨウ化物製剤に加工する方法が開示されている。
特許文献４には、高純度で固化しない均質な強度を有する結晶性無機化合物の造粒方法を提供するために、結晶性無機化合物の粉体をロール式圧縮造粒機によって造粒化する際に、解砕、フルイ分け工程において高温で造粒品を処理する方法が開示されており、結晶性無機化合物の一例として、ヨウ化カリウムが挙げられている。
In Patent Document 2, in order to provide metal iodide granules having high workability, an aqueous solution of metal iodide is continuously supplied to a fluidized bed spray granulation dryer to dry granulate the metal iodide. A method is disclosed.
In Patent Document 3, in order to prevent agglomeration due to consolidation / aggregation of metal iodide, a briquetting roll type compression granulation method is used to form metal iodide into a granule having a particle diameter of 3 mm or more. Is disclosed as a metal iodide preparation having 30% or more of the total.
Patent Document 4 discloses a method for granulating a crystalline inorganic compound powder by a roll-type compression granulator in order to provide a method for granulating a crystalline inorganic compound having high purity and uniform strength that does not solidify. Discloses a method of treating a granulated product at a high temperature in the crushing and sieving process, and potassium iodide is cited as an example of a crystalline inorganic compound.
ところで、金属ヨウ化物は、上述のように偏光膜の材料やナイロン安定剤、医薬原料等として多く用いられるが、これらのような用途に用いる場合には、高純度の金属ヨウ化物が求められる。よって、リン酸水素二ナトリウムや炭酸マグネシウム等といった添加剤を添加し不純物を増加させる特許文献１の方法は、金属ヨウ化物の固結防止方法としては不適である。
特許文献２の方法では、ある程度の固結防止効果は認められるものの、保管試験を実施すると一ヶ月足らずで固結の兆候が認められ、固結防止効果が不十分である。
特許文献３の方法でも、ある程度の固結防止効果は認められるものの、長期間保存した場合には固結が生じ、固結防止効果が不十分である。
特許文献４の方法では、結晶性無機化合物を高温（６０〜１２０℃）で処理することが必須要件となっているが、ヨウ化カリウムを代表とする大部分の金属ヨウ化物は、熱あるいは光によって遊離ヨウ素が発生することが知られている。よって、高温での処理により、金属ヨウ化物の品質が低下することは明らかであり、特許文献４の方法は金属ヨウ化物の固結防止方法に適していない。
By the way, as described above, metal iodide is often used as a material for a polarizing film, a nylon stabilizer, a pharmaceutical raw material, and the like. However, when used for such applications, high-purity metal iodide is required. Therefore, the method of Patent Document 1 in which an additive such as disodium hydrogen phosphate or magnesium carbonate is added to increase impurities is not suitable as a method for preventing metal iodide consolidation.
In the method of Patent Document 2, a certain degree of anti-caking effect is recognized, but when a storage test is performed, signs of caking are recognized in less than one month, and the anti-caking effect is insufficient.
Even with the method of Patent Document 3, although a certain degree of anti-caking effect is recognized, caking occurs when stored for a long period of time, and the anti-caking effect is insufficient.
In the method of Patent Document 4, it is essential to treat the crystalline inorganic compound at a high temperature (60 to 120 ° C.). However, most metal iodides represented by potassium iodide are heat or light. Is known to generate free iodine. Therefore, it is clear that the quality of the metal iodide is deteriorated by the treatment at a high temperature, and the method of Patent Document 4 is not suitable as a method for preventing the metal iodide from solidifying.
そこで、本発明は上記事情に鑑みてなされたものであり、長期間保存した場合であっても固結が十分に防止される金属ヨウ化物の製造方法を提供することを目的とする。 Then, this invention is made | formed in view of the said situation, and it aims at providing the manufacturing method of the metal iodide by which caking is fully prevented even if it is a case where it preserve | saves for a long period of time.
本発明者らは、鋭意研究を重ねた結果、金属ヨウ化物の粉末を１０〜５０℃で、圧壊強度が４ｋｇｆ以上、粒子径が５〜２０ｍｍとなるように圧縮成型する、錠剤型の金属ヨウ化物の製造方法により、上記目的を達成できることを見出した。 As a result of intensive research, the present inventors have carried out compression molding of a metal iodide powder at 10 to 50 ° C. so that the crushing strength is 4 kgf or more and the particle diameter is 5 to 20 mm. It has been found that the above object can be achieved by a method for producing a chemical compound.
本発明によれば、長期間保存した場合であっても固結が十分に防止される金属ヨウ化物の製造方法を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, even if it is a case where it preserve | saves for a long time, the manufacturing method of the metal iodide which can fully prevent solidification can be provided.
本発明の製造方法においては、錠剤の圧壊強度が４ｋｇｆ以上となるため、得られる錠剤の投影断面積が１ｃｍ２であるとすると、４ｋｇ／ｃｍ２以上の圧力に耐えられると計算される。金属ヨウ化物の代表例であるヨウ化カリウムの粉末は、従来、３５Ｌのファイバードラム等に充填していたが、この場合のファイバードラムの底部におけるヨウ化カリウムの粉末が自重で受ける圧力は最大で約０．５２ｋｇ／ｃｍ２と計算される。これらの計算を考慮すると、本発明の製造方法を用いた場合には、錠剤の圧壊強度が自重で受ける圧力よりも十分に大きいために、錠剤自体がつぶれて表面積の大きい粉末となることが防止され、結果として吸湿及びそれに伴う固結が防止される。 In the production method of the present invention, since the crushing strength of the tablet is 4 kgf or more, if the projected cross-sectional area of the obtained tablet is 1 cm 2, it is calculated that the tablet can withstand a pressure of 4 kg / cm 2 or more. Conventionally, potassium iodide powder, which is a typical example of metal iodide, has been filled in a 35 L fiber drum or the like. In this case, the pressure applied to the potassium iodide powder at the bottom of the fiber drum by its own weight is the maximum. It is calculated as about 0.52 kg / cm 2 . Considering these calculations, when the manufacturing method of the present invention is used, the tablet's crushing strength is sufficiently larger than the pressure received by its own weight, preventing the tablet itself from collapsing into a powder with a large surface area. As a result, moisture absorption and accompanying caking are prevented.
本発明の製造方法においては、金属ヨウ化物の粉末を１０〜５０℃で圧縮成型することにより、遊離ヨウ素の発生を防止し、これによる金属ヨウ化物の純度低下を防止することができる。 In the production method of the present invention, the metal iodide powder is compression molded at 10 to 50 ° C., thereby preventing the generation of free iodine and preventing the purity of the metal iodide from being lowered.
さらに、本発明の製造方法においては、錠剤の粒子径が５ｍｍ以上となるため、粒子径が５ｍｍ未満である場合に生じる不具合を防止することができる。すなわち、粒子径が５ｍｍ未満である場合に、打錠機を用いて成型を行うと臼や杵の数が粒子径の大きさに反比例して多量になることから初期コストが増大したり、粒子が細かくなることで時間当たりの生産性が低下したりして、トータルコストやハンドリングに問題が発生する傾向があるという不具合を防止することができる。さらにまた、本発明の製造方法においては、錠剤の粒子径が２０ｍｍ以下となるため、粒子径が２０ｍｍを超える場合に生じる不具合を防止することができる。すなわち、粒子径が２０ｍｍを超える場合に、金属ヨウ化物を溶媒に溶解させるのに長時間要するため、作業性が低下するという不具合を防止することができる。 Furthermore, in the manufacturing method of this invention, since the particle diameter of a tablet will be 5 mm or more, the malfunction which arises when a particle diameter is less than 5 mm can be prevented. That is, when the particle diameter is less than 5 mm, when the molding is performed using a tableting machine, the initial cost increases because the number of mortars and ridges increases in inverse proportion to the size of the particle diameter. As a result, the productivity per hour is reduced and the problem that the total cost and handling tend to occur can be prevented. Furthermore, in the manufacturing method of this invention, since the particle diameter of a tablet will be 20 mm or less, the malfunction which arises when a particle diameter exceeds 20 mm can be prevented. That is, when the particle diameter exceeds 20 mm, it takes a long time to dissolve the metal iodide in the solvent, so that it is possible to prevent a problem that workability is lowered.
本発明の製造方法においては、上記圧縮成型が打錠式の乾式圧縮造粒機により行われることが好ましい。これにより、上述の固結防止効果がより向上する。 In the production method of the present invention, the compression molding is preferably performed by a tableting dry compression granulator. Thereby, the above-mentioned caking prevention effect improves more.
本発明の製造方法においては、上記圧縮成型における打錠圧力が１〜２０ｋＮであることが好ましい。これにより、上述の固結防止効果が更に向上する。 In the manufacturing method of this invention, it is preferable that the tableting pressure in the said compression molding is 1-20 kN. Thereby, the above-mentioned caking prevention effect further improves.
本発明の製造方法は、金属ヨウ化物がアルカリ金属ヨウ化物又はアルカリ土類金属ヨウ化物である場合により好適に用いられる。 The production method of the present invention is more preferably used when the metal iodide is an alkali metal iodide or an alkaline earth metal iodide.
本発明によれば、長期間保存した場合であっても固結が十分に防止される金属ヨウ化物の製造方法が提供される。さらに本発明の製造方法により得られる金属ヨウ化物は、錠剤状であるため、粉塵が舞うこともなく、使用者にとってのハンドリング性が飛躍的に改善し、容易に取り扱うことができる。 ADVANTAGE OF THE INVENTION According to this invention, the manufacturing method of the metal iodide in which caking is fully prevented even if it is a case where it preserve | saves for a long period of time is provided. Furthermore, since the metal iodide obtained by the production method of the present invention is in the form of a tablet, dust does not fly, handling property for the user is dramatically improved, and it can be handled easily.
以下、本発明の好適な実施形態について詳細に説明するが、本発明はこれに限定されるものでない。 Hereinafter, preferred embodiments of the present invention will be described in detail, but the present invention is not limited thereto.
本発明の製造方法は、例えば、ヨウ化リチウム、ヨウ化ナトリウム、ヨウ化カリウム、ヨウ化ルビジウム、ヨウ化セシウム等のアルカリ金属ヨウ化物、ヨウ化カルシウム、ヨウ化ストロンチウム等のアルカリ土類金属ヨウ化物、ヨウ化アルミニウムといった金属ヨウ化物に用いることができる。このうち、アルカリ金属ヨウ化物及びアルカリ土類金属ヨウ化物により好適に本発明の製造方法を用いることができ、ヨウ化カリウムに特に好適に本発明の製造方法を用いることができる。 The production method of the present invention includes, for example, alkali metal iodides such as lithium iodide, sodium iodide, potassium iodide, rubidium iodide and cesium iodide, and alkaline earth metal iodides such as calcium iodide and strontium iodide. And metal iodide such as aluminum iodide. Among these, the production method of the present invention can be suitably used for alkali metal iodides and alkaline earth metal iodides, and the production method of the present invention can be particularly suitably used for potassium iodide.
本発明の製造方法で用いられる金属ヨウ化物の粉末は、基本的に水や固結防止剤等の不純物を含むものではないが、若干量の不純物の混入を妨げるものではない。また、金属ヨウ化物の粉末としては、晶析乾燥品の粉末等を用いることができるが、流動乾燥機等により乾燥され、粒子径が１０００μｍ以下で揃っているものを用いることが好ましい。 The metal iodide powder used in the production method of the present invention basically does not contain impurities such as water and an anti-caking agent, but does not hinder the introduction of a slight amount of impurities. As the metal iodide powder, a crystallized dry powder or the like can be used, but it is preferable to use a powder which is dried by a fluid dryer or the like and has a particle diameter of 1000 μm or less.
本発明の製造方法における圧縮成型の際の温度は、１０〜５０℃であり、１０〜４０℃であることが好ましく、常温（１５〜２５℃）であることがより好ましい。 The temperature at the time of compression molding in the production method of the present invention is 10 to 50 ° C, preferably 10 to 40 ° C, and more preferably room temperature (15 to 25 ° C).
本発明の製造方法における圧縮成型は、例えば乾式圧縮造粒機を用いて行うことができる。乾式圧縮造粒機には大きく分けて圧縮ロール式、ブリケッティング・ロール式、打錠式の３つに分類されるが、このうち打錠式のもの（打錠機）が好ましい。打錠機には大きく分けて単発式のエキセントリック型、ロータリー型があるが、このうちロータリー型のものが好ましい。ロータリー型の打錠機を用いる場合には、ローター回転数を３０〜６０ｒｐｍで操作し、打錠圧力を１〜１０ｋＮ（キロニュートン）として打錠する。このようなロータリー型の打錠機により、１時間当たり１００〜５００ｋｇの錠剤を生産できることが見込まれる。 The compression molding in the production method of the present invention can be performed using, for example, a dry compression granulator. Dry compression granulators are roughly classified into three types: a compression roll type, a briquetting roll type, and a tableting type, and among these, a tableting type (tablet press) is preferred. The tableting machines are roughly classified into single-shot eccentric type and rotary type. Of these, the rotary type is preferable. When a rotary type tableting machine is used, tableting is performed by operating the rotor speed at 30 to 60 rpm and the tableting pressure at 1 to 10 kN (kilonewtons). It is expected that tablets of 100 to 500 kg per hour can be produced by such a rotary type tableting machine.
打錠式の乾式圧縮造粒機を用いた場合の上記圧縮成型における打錠圧力は、１〜２０ｋＮであることが好ましく、３〜１５ｋＮであることがより好ましい。 The tableting pressure in the compression molding when using a tableting dry compression granulator is preferably 1 to 20 kN, more preferably 3 to 15 kN.
本発明の製造方法における錠剤型の金属ヨウ化物の圧壊強度は、４ｋｇｆ以上である。なお、圧壊強度の上限については特に限定されないが、例えば３０ｋｇｆ以下とすることができる。 The crushing strength of the tablet-type metal iodide in the production method of the present invention is 4 kgf or more. The upper limit of the crushing strength is not particularly limited, but can be, for example, 30 kgf or less.
本発明の製造方法における錠剤型の金属ヨウ化物の粒子径は、５〜２０ｍｍであり、７〜１５ｍｍであることが好ましい。 The particle size of the tablet-type metal iodide in the production method of the present invention is 5 to 20 mm, and preferably 7 to 15 mm.
本発明は上述の製造方法に加えて、金属ヨウ化物の粉末を１０〜５０℃で圧縮成型し、圧壊強度が４ｋｇｆ以上であり、粒子径が５〜２０ｍｍである錠剤に加工することを特徴とする、金属ヨウ化物の固結防止方法を提供するものである。 In addition to the above production method, the present invention is characterized in that a metal iodide powder is compression molded at 10 to 50 ° C. and processed into a tablet having a crushing strength of 4 kgf or more and a particle diameter of 5 to 20 mm. The present invention provides a method for preventing caking of metal iodide.
以下、本発明を実施例により詳細に説明するが、本発明はこれに限定されるものでない。なお、圧壊強度の測定には、株式会社藤原製作所製 木屋式デジタル硬度計 ＫＨＴ−２０Ｎを使用した。 EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, this invention is not limited to this. For the measurement of the crushing strength, a Kiya type digital hardness tester KHT-20N manufactured by Fujiwara Seisakusho Co., Ltd. was used.
（実施例１）
流動乾燥機を使って製造した粒子径１０００μｍ以下（平均粒子径２５０μｍ）のヨウ化カリウム原料粉末を、常温でロータリー型打錠機を使って粒子径９ｍｍの錠剤に成型した。ロータリー型打錠機の打錠圧力は３〜５ＫＮとして、ローターの回転数は、キャッピングや、粉末の杵及び臼への付着が起こらない様に、且つ成型速度を考慮した最適条件である５０ｒｐｍとした。得られた錠剤の圧壊強度は約５〜７ｋｇｆであった。得られた錠剤の写真を図１に示す。なお、「キャッピング」とは、打錠式の圧縮造粒機の臼や杵に錠剤の一部が結着し、この結着部分が帽子状に剥離する現象をいう。
Example 1
A potassium iodide raw material powder having a particle size of 1000 μm or less (average particle size of 250 μm) produced using a fluid dryer was molded into a tablet having a particle size of 9 mm at room temperature using a rotary tableting machine. The tableting pressure of the rotary type tableting machine is 3 to 5 KN, and the rotation speed of the rotor is 50 rpm, which is the optimum condition in consideration of molding speed so that capping and adhesion of the powder to the pestle and die do not occur. did. The crushing strength of the obtained tablet was about 5 to 7 kgf. The photograph of the obtained tablet is shown in FIG. The “capping” refers to a phenomenon in which a part of the tablet is bound to a mortar or pestle of a tablet-type compression granulator and the bound part is peeled off in a hat shape.
（実施例２）
打錠圧力を１〜１．７ＫＮにした以外は実施例１と同様にして錠剤を製造した。得られた錠剤の圧壊強度は約６〜１０ｋｇｆであった。また、錠剤の製造中、キャッピング及び粉末の杵及び臼への付着は起こらなかった。
(Example 2)
Tablets were produced in the same manner as in Example 1 except that the tableting pressure was changed to 1 to 1.7 KN. The crushing strength of the obtained tablets was about 6 to 10 kgf. Also, no capping or powder sticking to the wrinkles and mortars occurred during tablet manufacture.
（比較例１）
流動乾燥機を使って製造した１０００μｍ以下の粒子径のヨウ化カリウム原料粉末を、ブリケッティング・ロ−ル方式の圧縮式造粒機を用いて造粒した。造粒に際しては、圧縮式造粒機のロール圧力を約５ＭＰａとするとともに、回転ロールのポケットを豆炭状、アーモンド状等に色々変えて、種々の形状の造粒体を製造した。
しかしいずれの場合も、得られた造粒体は、ラミネーションを起こしやすく、形の整ったブリケット型ではなかった。さらに、得られた造粒体は、薄い部分で繋がった形で排出されたため、その薄い部分で割れて破砕されたり、粉末となったりしたものが混入した（これらのように上手く成型されなかった造粒体の割合は２０％〜３０％と推定される）。よって、後述する保管状態の評価等の試験を行うことができなかった。なお、「ラミネーション」とは、錠剤が層状をなすように剥離したり、割れたりする現象をいう。
(Comparative Example 1)
A potassium iodide raw material powder having a particle diameter of 1000 μm or less produced using a fluid dryer was granulated using a briquetting roll type compression granulator. When granulating, the roll pressure of the compression granulator was set to about 5 MPa, and the pockets of the rotating roll were variously changed to bean charcoal, almond, etc. to produce granulates of various shapes.
However, in any case, the obtained granulated body was prone to lamination and was not a well-formed briquette type. Furthermore, since the obtained granule was discharged in a form connected by a thin part, it was broken and crushed in the thin part, or a powder was mixed (not molded as well as these) The proportion of the granulated body is estimated to be 20% to 30%). Therefore, it was not possible to perform tests such as evaluation of storage conditions described later. “Lamination” refers to a phenomenon in which a tablet peels or cracks in a layered manner.
（比較例２）
実施例１で用いたヨウ化カリウム原料粉末と同様の、流動乾燥機を使って製造した粒子径１０００μｍ以下（平均粒子径２５０μｍ）のヨウ化カリウム粉末を用意した。
(Comparative Example 2)
Similar to the potassium iodide raw material powder used in Example 1, a potassium iodide powder having a particle size of 1000 μm or less (average particle size of 250 μm) produced using a fluidized dryer was prepared.
［錠剤の物性の評価］
実施例１及び２の錠剤について、表面積、粒子密度、比表面積、かさ密度及び圧壊強度の評価を行った。さらに、比較対象として、比較例２の粉末についても、表面積、粒子密度、比表面積及びかさ密度の評価を行った。これらの結果を表１に示す。なお、表１中、表面積を求めるために、比較例２の粒子密度として真密度を示している。また、表面積、粒子密度、比表面積、かさ密度は次のようにして求めた。
まず、実施例１及び２で成型された錠剤のうち１個を取り出し、その体積及び表面積を算出するとともに、重量を測定した。比表面積は、この表面積の値を重量の値で除して算出し、また粒子密度は、重量の値を体積の値で除して算出した。
また、比較例２の粉末は粒度分布を持っているため、上記の方法で粒子密度等を求めることはできない。そこで、粉末を篩にかけて粒度分布を求めた上で、それぞれの粒径の真球として表面積、体積を求め、これらの値及び上記真密度から比表面積を求めている。
実施例１及び２の錠剤のかさ密度は、２５０ｍＬのメスシリンダーに錠剤を入れて重量を測定し、この重量を体積で除して算出した。また、比較例２の粉末のかさ密度は同様な操作を１００ｍＬのメスシリンダーを用いて行い、算出した。
[Evaluation of physical properties of tablets]
The tablets of Examples 1 and 2 were evaluated for surface area, particle density, specific surface area, bulk density and crushing strength. Furthermore, as a comparison object, the surface area, particle density, specific surface area, and bulk density of the powder of Comparative Example 2 were also evaluated. These results are shown in Table 1. In Table 1, the true density is shown as the particle density of Comparative Example 2 in order to obtain the surface area. The surface area, particle density, specific surface area, and bulk density were determined as follows.
First, one of the tablets molded in Examples 1 and 2 was taken out, its volume and surface area were calculated, and its weight was measured. The specific surface area was calculated by dividing the surface area value by the weight value, and the particle density was calculated by dividing the weight value by the volume value.
Further, since the powder of Comparative Example 2 has a particle size distribution, the particle density or the like cannot be obtained by the above method. Therefore, after the particle size distribution is obtained by sieving the powder, the surface area and volume are obtained as true spheres of the respective particle diameters, and the specific surface area is obtained from these values and the true density.
The bulk density of the tablets of Examples 1 and 2 was calculated by placing the tablets in a 250 mL graduated cylinder, measuring the weight, and dividing this weight by the volume. The bulk density of the powder of Comparative Example 2 was calculated by performing the same operation using a 100 mL graduated cylinder.
表１から明らかであるように、実施例１及び２の錠剤は、比較例２の粉末と比較して比表面積が非常に小さい。よって、固結問題の遠因でもある吸湿性が低下することは容易に想像できる。また、実施例１及び２の錠剤のかさ密度は比較例２の粉末とほぼ同等の値である。よって、実施例１及び２の錠剤は、比較例２のような粉末を包装していた従来の包装材と同様なものを用いて包装できることが分かった。 As is clear from Table 1, the tablets of Examples 1 and 2 have a very small specific surface area compared to the powder of Comparative Example 2. Therefore, it can be easily imagined that the hygroscopicity, which is a cause of the caking problem, is reduced. Moreover, the bulk density of the tablets of Examples 1 and 2 is almost the same value as the powder of Comparative Example 2. Therefore, it turned out that the tablet of Example 1 and 2 can be packaged using the same thing as the conventional packaging material which packaged the powder like the comparative example 2. FIG.
［錠剤の固結防止性の評価］
実施例１の錠剤及び比較例２の粉末について、次のような方法で保管状態の評価を行った。
実施例１の錠剤１００ｋｇをポリ袋で包装し、包装された錠剤を５００Φの１００Ｌフレコン（登録商標）中で１ヶ月間保管し、固結の発生を目視で観察した。保管後の錠剤は、包装する前とほとんど変化がなく、全く固結しなかった。
これに対し、比較例２の粉末はダンボール包装で１ヶ月間保管したところ、ダンボールの形状に沿って粉末が固まった。
[Evaluation of anti-caking properties of tablets]
About the tablet of Example 1 and the powder of Comparative Example 2, the storage state was evaluated by the following method.
100 kg of the tablet of Example 1 was packaged in a plastic bag, and the packed tablet was stored in a 100 L FIBC (registered trademark) of 500Φ for 1 month, and the occurrence of caking was visually observed. The tablet after storage had almost no change from that before packaging, and was not consolidated at all.
On the other hand, when the powder of Comparative Example 2 was stored in cardboard packaging for one month, the powder hardened along the shape of the cardboard.
［錠剤の溶解特性の評価１］
実施例１の錠剤について、次のような方法で溶解特性の評価を行った。
１Ｌのビーカを２個用意し、各ビーカに５００ｍｌのイオン交換水を入れ、それぞれマグネティックスターラーで１２０〜１５０ｒｐｍの速度で攪拌しながら、上記サンプルを投入し、液温度４０℃又は２５℃で、サンプルの溶解時間を評価した。サンプル量は液温が４０℃である場合には２５ｇ、液温が２５℃である場合には５００ｇとした。なお、溶解時間とはサンプルが完全に溶解するまでに要した時間であり、具体的にはサンプルの投入後、固体物の存在が目視で確認することができなくなるまでの時間である。得られた結果を表２に示す。
[Evaluation of tablet dissolution characteristics 1]
The dissolution characteristics of the tablet of Example 1 were evaluated by the following method.
Prepare two 1L beakers, put 500ml of ion-exchanged water into each beaker, add the above sample while stirring at a speed of 120-150rpm with a magnetic stirrer, and at a liquid temperature of 40 ° C or 25 ° C, The dissolution time of was evaluated. The sample amount was 25 g when the liquid temperature was 40 ° C., and 500 g when the liquid temperature was 25 ° C. The dissolution time is the time required until the sample is completely dissolved, and specifically, the time until the presence of a solid substance cannot be visually confirmed after the sample is charged. The obtained results are shown in Table 2.
表２から、液温を４０℃及び２５℃とした条件のそれぞれで、実施例１の錠剤は十分な溶解特性を示すことが明らかとなった。 From Table 2, it was revealed that the tablet of Example 1 exhibits sufficient dissolution characteristics under the conditions where the liquid temperature was 40 ° C. and 25 ° C.
（実施例３〜７）
錠剤の粒子径をそれぞれ５．０、７．０、９．０、１１．５、１５．０ｍｍとし、打錠圧力を３ｋＮとした他は、実施例１と同様にして、実施例３〜７のヨウ化カリウムの錠剤を製造した。得られた錠剤について、上述の［錠剤の物性の評価］に記載の方法に基づき、表面積、粒子密度、比表面積、かさ密度等を求めた。その結果を表３に示す。なお、錠剤の粒子径が９．０ｍｍの場合には、打錠圧力を３、５、８ｋＮと変化させて錠剤の製造を行ったが、錠剤の物性に特筆すべき変化は見られなかった。
(Examples 3 to 7)
Examples 3 to 7 were carried out in the same manner as in Example 1 except that the tablet particle diameters were 5.0, 7.0, 9.0, 11.5 and 15.0 mm, respectively, and the tableting pressure was 3 kN. Of potassium iodide tablets were prepared. About the obtained tablet, surface area, particle density, specific surface area, bulk density and the like were determined based on the method described in [Evaluation of physical properties of tablet]. The results are shown in Table 3. When the tablet particle size was 9.0 mm, the tablet was manufactured while changing the tableting pressure to 3, 5, and 8 kN. However, there was no noticeable change in the physical properties of the tablet.
［錠剤の溶解特性の評価２］
実施例３〜７の錠剤について、次のような方法で溶解特性の評価を行った。
２０〜１００ｍｌの容器で、「錠剤重量／水液量」の値が約５．４ｗ／ｖ％となるように、錠剤の個数及び水液量を調整するとともに、錠剤の大きさに合わせて回転子の大きさと回転数を調整し、２５〜２７℃の溶液温度で錠剤が完全に溶解するまでにかかる時間（溶解時間）を測定した。その結果を表４に示す。
[Evaluation of dissolution characteristics of tablets 2]
The dissolution characteristics of the tablets of Examples 3 to 7 were evaluated by the following method.
In a 20 to 100 ml container, adjust the number of tablets and the amount of aqueous liquid so that the value of “tablet weight / aqueous liquid amount” is about 5.4 w / v%, and rotate according to the size of the tablet. The size of the child and the number of rotations were adjusted, and the time (dissolution time) required for the tablet to completely dissolve at a solution temperature of 25 to 27 ° C. was measured. The results are shown in Table 4.
また、錠剤の粒径と溶解時間との関係、及び錠剤の粒径と錠剤の高さとの関係をそれぞれ図２に示す。 FIG. 2 shows the relationship between the tablet particle size and the dissolution time, and the relationship between the tablet particle size and the tablet height, respectively.
Claims (4)
The manufacturing method as described in any one of Claims 1-3 whose said metal iodide is an alkali metal iodide or an alkaline-earth metal iodide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008122565A JP5070121B2 (en) | 2007-11-15 | 2008-05-08 | Method for producing tablet-shaped metal iodide |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007297100 | 2007-11-15 | ||
| JP2007297100 | 2007-11-15 | ||
| JP2008122565A JP5070121B2 (en) | 2007-11-15 | 2008-05-08 | Method for producing tablet-shaped metal iodide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009137824A true JP2009137824A (en) | 2009-06-25 |
| JP5070121B2 JP5070121B2 (en) | 2012-11-07 |
Family
ID=40708841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008122565A Active JP5070121B2 (en) | 2007-11-15 | 2008-05-08 | Method for producing tablet-shaped metal iodide |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP5070121B2 (en) |
| KR (1) | KR101191718B1 (en) |
| CN (1) | CN101434131A (en) |
| TW (1) | TWI383840B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017019688A (en) * | 2015-07-10 | 2017-01-26 | 株式会社合同資源 | Manufacturing method of metal iodide tablet |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240039868A (en) * | 2022-09-20 | 2024-03-27 | 한국유나이티드제약 주식회사 | Pharmaceutical composition for thyroid protection and manufacturing method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06285355A (en) * | 1993-04-02 | 1994-10-11 | Otsuka Chem Co Ltd | Dry granulating method for crystalline inorganic compound |
| JPH09156920A (en) * | 1995-11-30 | 1997-06-17 | Nippo Kagaku Kk | Granule of metal iodide and method for granulating the same |
| JPH1135413A (en) * | 1997-07-15 | 1999-02-09 | Mitsui Chem Inc | Formed solid iodophor |
| JP2004217467A (en) * | 2003-01-15 | 2004-08-05 | Godo Shigen Sangyo Kk | Metallic iodide product and package of metallic iodide product |
| JP2005047764A (en) * | 2003-07-30 | 2005-02-24 | Nippo Kagaku Kk | Manufacturing method of particulate metal iodide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4976660B2 (en) * | 2005-05-12 | 2012-07-18 | 合同資源産業株式会社 | Method for producing alkali iodide |
-
2008
- 2008-05-05 TW TW097116540A patent/TWI383840B/en active
- 2008-05-08 JP JP2008122565A patent/JP5070121B2/en active Active
- 2008-05-22 CN CNA2008100984310A patent/CN101434131A/en active Pending
- 2008-05-22 KR KR1020080047612A patent/KR101191718B1/en active IP Right Grant
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06285355A (en) * | 1993-04-02 | 1994-10-11 | Otsuka Chem Co Ltd | Dry granulating method for crystalline inorganic compound |
| JPH09156920A (en) * | 1995-11-30 | 1997-06-17 | Nippo Kagaku Kk | Granule of metal iodide and method for granulating the same |
| JPH1135413A (en) * | 1997-07-15 | 1999-02-09 | Mitsui Chem Inc | Formed solid iodophor |
| JP2004217467A (en) * | 2003-01-15 | 2004-08-05 | Godo Shigen Sangyo Kk | Metallic iodide product and package of metallic iodide product |
| JP2005047764A (en) * | 2003-07-30 | 2005-02-24 | Nippo Kagaku Kk | Manufacturing method of particulate metal iodide |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017019688A (en) * | 2015-07-10 | 2017-01-26 | 株式会社合同資源 | Manufacturing method of metal iodide tablet |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090050922A (en) | 2009-05-20 |
| JP5070121B2 (en) | 2012-11-07 |
| TW200920481A (en) | 2009-05-16 |
| KR101191718B1 (en) | 2012-10-16 |
| CN101434131A (en) | 2009-05-20 |
| TWI383840B (en) | 2013-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5888765B2 (en) | Coal ash compaction granulator | |
| KR101867621B1 (en) | Compressible and free-flow co-agglomerates of mannitol and granular starch | |
| CN109531857B (en) | Preparation method of hyaluronic acid or salt particles thereof and obtained product | |
| JP5070121B2 (en) | Method for producing tablet-shaped metal iodide | |
| JP2020097011A (en) | Method of producing granulated substance of lithium adsorbent | |
| Kawashima et al. | Development of agglomerated crystals of ascorbic acid by the spherical crystallization technique for direct tableting, and evaluation of their compactibilities [Translated] | |
| JP2004217467A (en) | Metallic iodide product and package of metallic iodide product | |
| JP5074828B2 (en) | Solidified dialysis agent and method for producing the same | |
| CN100508966C (en) | Pharmaceutical preparation containing gabapentin | |
| JP2012092036A (en) | Method for producing salt of carnitine | |
| JP2017019688A (en) | Manufacturing method of metal iodide tablet | |
| JPWO2004006945A1 (en) | Kampo extract-containing tablet composition and method for producing the same | |
| IE81025B1 (en) | Processing of active agents | |
| JP2729316B2 (en) | Nitrate briquette and method for producing the same | |
| JPS59232078A (en) | Production of granular agent to preserve freshness | |
| JP2009233008A (en) | Dialysis agent and method for producing the same | |
| US11697632B2 (en) | Storage stable choline chloride compositions | |
| JP5385712B2 (en) | Dialysis agent and method for producing dialysis agent | |
| AU2017222125B2 (en) | Glycine particles | |
| JP6506752B2 (en) | Super fast disintegrating tablet formulation for API miglitol | |
| JP2012148997A (en) | Guanidine thiocyanate compact | |
| TW202325393A (en) | Caking-resistant neopentyl glycol compacts and process for producing caking-resistant neopentyl glycol compacts | |
| JPS63282116A (en) | Granular calcium hydroxide and manufacture thereof | |
| JP2021001156A (en) | Propionic acid metal salt granules and method for producing the same | |
| JP2754611B2 (en) | Method for producing granules of solid chlorine agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111003 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120403 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120601 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120814 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120820 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150824 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5070121 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |